FRAT1 antibody (AA 161-260) (AbBy Fluor® 750)
-
- Target See all FRAT1 Antibodies
- FRAT1 (Frequently Rearranged in Advanced T-Cell Lymphomas (FRAT1))
-
Binding Specificity
- AA 161-260
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This FRAT1 antibody is conjugated to AbBy Fluor® 750
-
Application
- Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc))
- Predicted Reactivity
- Human,Mouse,Rat,Dog,Cow
- Purification
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human FRAT1
- Isotype
- IgG
- Top Product
- Discover our top product FRAT1 Primary Antibody
-
-
- Application Notes
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Expiry Date
- 12 months
-
- Target
- FRAT1 (Frequently Rearranged in Advanced T-Cell Lymphomas (FRAT1))
- Alternative Name
- FRAT1 (FRAT1 Products)
- Synonyms
- FRAT1 antibody, frat1 antibody, AW060382 antibody, gbp antibody, FRAT1, WNT signaling pathway regulator antibody, GSK-3 binding protein FRAT1 antibody, frequently rearranged in advanced T cell lymphomas antibody, frequently rearranged in advanced T-cell lymphomas antibody, frequently rearranged in advanced T-cell lymphomas 1 S homeolog antibody, FRAT1 antibody, frat1 antibody, Frat1 antibody, frat1.S antibody
- Background
-
Synonyms: FRAT 1, frequently rearranged in advanced T cell lymphomas, Frequently rearranged in advanced T-cell lymphomas, GSK 3 binding protein FRAT1, proto oncogene FRAT1, FRAT1_HUMAN.
Background: FRAT1 and FRAT2 were originally characterized as proteins frequently rearranged in advanced T cell lymphoma, and they have since been identified as proto-oncogenes involved in tumorigenesis. These proteins share significant homology with the Xenopus glycogen synthase kinase-3 (xGSK-3) binding protein, which is designated GBP and is essential for the formation of the dorsal-ventral axis during embryonic development. Establishment of these embryonic axes is mediated by the Wnt intracellular signaling pathway. Wnt signaling is regulated in part by the activity of GSK-3, which phosphorylates and thereby facilitates the degradation of ?catenin. GBP binds to GSK-3 and inhibits this phosphorylation, resulting in the accumulation of ?catenin and the subsequent transcription of Wnt target genes. Like GBP, FRAT2 has been shown to bind xGSK-3, suggesting that FRAT1 and FRAT2 may be GSK-3 regulatory proteins.
- Gene ID
- 10023
-